COVID-19 Vaccine and Biologics: An Impending Dilemma.

COVID-19 Vaccine and Biologics: An Impending Dilemma. J Drugs Dermatol. 2021 Jan 01;20(1):115-114 Authors: Hauptman M, Vasic J, Krase J Abstract The COVID-19 pandemic has forced healthcare providers across all specialties to adjust their methods of clinical practice. In Dermatology, focus on the continued safe usage of immunomodulating biologic therapies has attracted particular interest as the COVID-19 virus represents a novel infection risk. While guidance on biologic initiation and continuation has been established,1 the return to normalcy will likely involve a safe and effective vaccine. This vaccine(s) will represent a new clinical hurdle for prescribers who have continued patients on biologic therapy throughout the pandemic. PMID: 33400405 [PubMed - as supplied by publisher]
Source: Journal of Drugs in Dermatology - Category: Dermatology Tags: J Drugs Dermatol Source Type: research